| Name | COP1 E3 ubiquitin ligase |
| Description | Enables ubiquitin protein ligase activity. Involved in positive regulation of proteasomal ubiquitin-dependent protein catabolic process; proteasome-mediated ubiquitin-dependent protein catabolic process; and response to ionizing radiation. Part of Cul4A-RING E3 ubiquitin ligase complex. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n COP1 (constitutive photomorphogenesis protein 1, also known as RFWD2) is an E3 ubiquitin ligase that orchestrates protein turnover by marking specific substrates for proteasomal degradation. A series of studies show that COP1 plays a central role in multiple biological contexts. In several cancer models, COP1 acts as a tumor suppressor by targeting oncogenic transcription factors for degradation. For example, it ubiquitinates members of the ETS family (such as ETV1, ETV4, ETV5, and ETS2) as well as the oncoprotein c‐Jun, thereby dampening transcriptional programs that drive cell proliferation and tumor progression."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": " In triple‐negative breast cancer, decreased COP1 levels correlate with elevated ETV1 and a more aggressive phenotype."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Moreover, in hepatic and gastric cancers, aberrant COP1 expression has been linked to the disruption of p53 signaling, with COP1 targeting p53 for degradation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "8"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n The functional importance of COP1 extends beyond tumorigenesis. In developmental contexts such as lung morphogenesis, COP1-mediated degradation of ETS factors is critical for proper epithelial branching."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " In the nervous system, COP1 helps maintain proteostasis in microglia by limiting the accumulation of the pro-inflammatory transcription factor C/EBPβ, thereby suppressing neuroinflammatory and neurodegenerative cascades."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Furthermore, COP1 participates in broader regulatory networks through its interactions with other proteins. Its association with factors such as the pseudokinase STK40 underlines its role as an adaptor in ubiquitin-mediated signaling."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": " Collectively, these findings establish COP1 as an integrative node that governs key cellular processes—including tumor suppression, developmental patterning, and inflammatory responses—by modulating the stability of pivotal regulatory proteins.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Alberto C Vitari, Kevin G Leong, Kim Newton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "COP1 is a tumour suppressor that causes degradation of ETS transcription factors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature10005"}], "href": "https://doi.org/10.1038/nature10005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21572435"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21572435"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Domenico Migliorini, Sven Bogaerts, Dieter Defever, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI45784"}], "href": "https://doi.org/10.1172/JCI45784"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21403399"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21403399"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Yan Zhang, Shigetoshi Yokoyama, John C Herriges, et al. "}, {"type": "b", "children": [{"type": "t", "text": "E3 ubiquitin ligase RFWD2 controls lung branching through protein-level regulation of ETV transcription factors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1603310113"}], "href": "https://doi.org/10.1073/pnas.1603310113"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27335464"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27335464"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Zunamys I Carrero, Madhusudhan Kollareddy, Krishna M Chauhan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutant p53 protects ETS2 from non-canonical COP1/DET1 dependent degradation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.7275"}], "href": "https://doi.org/10.18632/oncotarget.7275"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26871468"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26871468"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Mao Ouyang, Hua Wang, Jieyi Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-015-1151-y"}], "href": "https://doi.org/10.1186/s12885-015-1151-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25884720"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25884720"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yun-Han Lee, Jesper B Andersen, Ho-Taek Song, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-10-0749"}], "href": "https://doi.org/10.1158/0008-5472.CAN-10-0749"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20959491"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20959491"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Yuan-fang Li, Dan-dan Wang, Bai-wei Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High level of COP1 expression is associated with poor prognosis in primary gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biol Sci (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/ijbs.4778"}], "href": "https://doi.org/10.7150/ijbs.4778"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23091414"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23091414"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Jiaxuan Zhang, Beibei Su, Chen Gong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-214 promotes apoptosis and sensitizes breast cancer cells to doxorubicin by targeting the RFWD2-p53 cascade."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2016.07.054"}], "href": "https://doi.org/10.1016/j.bbrc.2016.07.054"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27422604"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27422604"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Ada Ndoja, Rohit Reja, Seung-Hye Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ubiquitin Ligase COP1 Suppresses Neuroinflammation by Degrading c/EBPβ in Microglia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cell.2020.07.011"}], "href": "https://doi.org/10.1016/j.cell.2020.07.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32795415"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32795415"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Izabela Durzynska, Xiang Xu, Guillaume Adelmant, et al. "}, {"type": "b", "children": [{"type": "t", "text": "STK40 Is a Pseudokinase that Binds the E3 Ubiquitin Ligase COP1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Structure (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.str.2016.12.008"}], "href": "https://doi.org/10.1016/j.str.2016.12.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28089446"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28089446"}]}]}]}
|
| NCBI Gene ID | 64326 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
COP1 has 1,957 functional associations with biological entities spanning 5 categories (chemical, disease, phenotype or trait, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 22 datasets.
Click the + buttons to view associations for COP1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of COP1 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with COP1 protein from the CCLE Cell Line Proteomics dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of COP1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of COP1 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of COP1 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by COP1 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for COP1 protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with COP1 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with COP1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving COP1 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing COP1 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by COP1 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of COP1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of COP1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by COP1 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving COP1 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving COP1 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2024 | pathways involving COP1 protein from the Reactome Pathways 2024 dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of COP1 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of COP1 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of COP1 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of COP1 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |